ClinicalTrials.gg
RecruitingNCT05828992Integrate-HDUpdated May 19, 2023

Benchmarking Integrated Care for People Living With Huntington's Disease in England

An observational study in Huntington Disease, sponsored by University of Southampton. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-19.

Sponsored by University of Southampton · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2023, 2 years 11 months ago, but the record still lists the study as recruiting.
  • Started Feb 2023; still recruiting 3 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
60
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 51 studies in Huntington Disease with a site in United Kingdom — 10 open to participants now, 15 under way, 3 of them phase 3. Huntington Disease · United Kingdom.

Planned enrollment
11th of 13
60 · median 154
Started
2023
with 4 others
Observational
13 of 51
4 open now
Primary completion
2023-11
later than 0 of 14 live
Registered
41st of 51
by date

Among the 51 studies in Huntington Disease with a site in United Kingdom, this one is the 11th largest by planned enrollment of the 13 observational ones that give a count, is one of 5 that started in 2023, is one of 13 observational ones, reaches primary completion later than 0 of the 14 other live ones, and was the 41st registered.

Huntington Disease

293 studies on the registry are indexed under Huntington Disease; 54 are open to participants now.

Browse Huntington Disease studies →

Open to participants now

10 of the 51 studies in Huntington Disease with a site in United Kingdom are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 43 Huntington Disease studies recruiting now, 19 (44%) set no upper age limit and 20 (47%) stop at 75 or younger; 5 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 51 studies in Huntington Disease with a site in United Kingdom, or all of them as a file.
02

Study summary

The survey and full study information can be accessed here: https://southampton.qualtrics.com/jfe/form/SV_8iEedDJZy4xaiI6

The goal of this anonymous survey is to benchmark integrated care from the perspective of service users in adults living with Huntington's Disease, including informal caregivers. The main question it aims to answer is: Is standard of care for people living with HD in England person-centred integrated care from the perspective of service users?

Participants will complete a one-time anonymous survey either online or on paper, according to their preference, that takes an average of 20-30 minutes. Participants can take breaks as needed, picking up the survey from where it was paused.

Read the detailed description

Huntington's disease (HD) is a rare brain disease that affects people's coordination, thinking and behaviour. It is a hereditary condition, affecting families across generations. Because its complex, it requires different sectors working together. Different surveys can be found in long term neurological conditions indicating care fragmentation and unmet severe needs, but evidence in HD is sparse.

Two surveys were identified covering people's needs in the UK, dated from 2006 and 2010. When looking for models or approaches tested to improve outcomes for people living with HD, no studies were found. This is an underserved population with complex needs and care gaps that remain unaddressed.

Little is known about to what extent people living with HD are experiencing care coordination between services and sectors in England. Integrate-HD aims to find out what good, joined-up care looks like. The study will explore the views and experiences of people living with HD, to identify the changes needed to improve people's care and quality of life.

Integrate-HD is a national survey to benchmark integrated care from the perspective of people living with HD, including informal caregivers.

The study objectives are to:

  1. Characterise and classify systems/organisations in England involved in HD care in relation to person-centred integrated care from the perspective of users.
  2. Identify areas considered integrated by service users.
  3. Identify areas considered fragmented by service users.
  4. Map care resources used by people living with HD in England.
  5. Identify unmet care needs that need improvement.
03

Conditions studied

  • Huntington Disease

Browse trials for

Keywords

  • Integrated care
  • Huntington's Disease
  • Caregiver
  • Person-centred care
  • Benchmarking
  • Survey
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults with capacity living in England impacted by Huntington's Disease.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults with capacity living in England and fluent in English that are:

  • A person at risk of HD (where at least one parent is diagnosed with HD, therefore their offspring has 50% chance of developing the disease);
  • A person diagnosed with HD symptomatic or asymptomatic (after undergoing gene testing and having a positive result);
  • An informal caregiver supporting someone living with HD;
  • A former informal caregiver with experience of supporting someone living with HD in the last 3 years.

Exclusion criteria

Exclusion Criteria:

  • Below 18 years old;
  • Not fluent in English;
  • A person without capacity.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Person at risk

    Survey personalised for people living at risk of developing Huntington's Disease, meaning they have a parent diagnosed with HD but the person themselves have not undertaken a genetic test.

    Other: No intervention administered

  • Person HD gene positive asymptomatic

    Survey personalised for people that tested positive in their predictive genetic test but have not been yet diagnosed with clinical HD (manifest HD).

    Other: No intervention administered

  • Person HD gene positive symptomatic

    Survey personalised for people that tested positive in their predictive genetic test and have been diagnosed with clinical HD (manifest HD).

    Other: No intervention administered

  • Informal caregiver

    Survey personalised for people caring for another person diagnosed with HD.

    Other: No intervention administered

  • Former informal caregiver

    Survey personalised for people that have cared for another person diagnosed with HD in the last 3 years.

    Other: No intervention administered

Interventions

  • OtherNo intervention administered

    Survey only to gather people's experiences, opinions and needs.

06

What researchers measure

Primary outcomes

  1. Level of integration

    Using SPSS (version 27) responses will be analysed to explore the level of integration at specific systems or organizations in England to distinguish between "higher" and "lower" integration levels. The Likert-type scale section of the survey will have a scheme of points attributed to generate a key of integration level per domain.

    Time frame: 9 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — During this study all information collected from participants will be kept confidential. The data gathered through surveys is anonymous and will be stored on a secure database using only survey IDs. Any identifiable information, such as email contact provided at the end of the survey (in order to receive updates on the research or show interest in future research) will be stored separately to survey answers. All data will be stored on a password protected university computer/laptop or in a locked filing cabinet in a secure office in the University. This will only be accessible by the research team. The procedures for handling, processing, storing, and destroying data are compliant with the Data Protection Act 2018.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2023 (actual). Primary completion is estimated for Nov 2023, 9 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 12, 2023
First posted
Apr 25, 2023
StartActual
Feb 28, 2023
Primary completionEst.
Nov 30, 2023
CompletionEst.
Feb 29, 2024
Last update
May 19, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05828992
Collaborators
National Institute for Health Research, United Kingdom, Central Coast Research Institute for Integrated Care, Australia, University Hospital Southampton NHS Foundation Trust
Responsible party
Sponsor
First posted
Apr 25, 2023
Start date
Feb 28, 2023
Primary completion
Nov 30, 2023 (estimated)
Completion
Feb 29, 2024 (estimated)
Last update
May 19, 2023

Study contacts

Sandra B Pires, MSc
Contact
s.m.bartolomeu-pires@soton.ac.uk
07873576074
Mari Carmen Portillo, Professor
Contact
m.c.portillo-vega@soton.ac.uk
Sandra B Pires, MSc
principal investigator · University of Southampton

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion